developmental pathway potent v1v2-directed hiv-neutralizing antibodies 
antibodies capable neutralizing hiv- often target variable regions v1v2 hiv- envelope mechanism elicitation unclear define developmental pathway antibodies generated acquire requisite molecular characteristics neutralization twelve somatically related neutralizing antibodies cap256-vrc2601- isolated donor cap256 centre aids programme research south africa caprisa; antibody contained protruding tyrosine-sulphated anionic antigen-binding loop complementarity-determining region cdr h3 characteristic category antibodies unmutated ancestor emerged weeks - post-infection -residue cdr h3 neutralized virus superinfected individual weeks initial infection improved neutralization breadth potency occurred week modest affinity maturation preceded extensive diversification virus population hiv- v1v2-directed neutralizing antibodies can thus develop relatively rapidly initial selection b cells long cdr h3 limited subsequent somatic hypermutation data provide important insights relevant hiv- vaccine development 
